advertisement

WGA Rescources

Abstract #51262 Published in IGR 14-3

Long-term surgical results of initial trabeculotomy combined with sinusotomy performed inferiorly

Nambu H; Jo N; Kuro M; Minamino K; Ando A; Nambu R; Matsumura M; Takahashi K
Nippon Ganka Gakkai Zasshi 2012; 116: 740-750


PURPOSE: To evaluate retrospectively the long-term effects of initial trabeculotomy combined with sinusotomy performed inferiorly. PATIENTS AND METHOD: Enrolled were 128 eyes of 100 patients who received initial glaucoma surgery. In 36 eyes, the removal of Schlemm's canal endothelium was also performed (removed group). The results were compared with the intact group RESULTS: In the primary open angle glaucoma (POAG), mean intraocular pressure (IOP) at 3 years after surgery was 14.6 (intact) and 15.4 mmHg (removed). Kaplan-Meier life-table analysis showed that qualified success rates for the intact group at 8 years were 62.2% and for the removed group at 5 years 45.2% defined by 20 mmHg or lower. The results in developmental glaucoma (DG) were similar to those in POAG. No statistical differences in postoperative IOP between the intact and removed groups were seen in either POAG or DG. In exfoliation glaucoma (XFG), mean IOPs for the intact group at 3 years were 17.3 mmHg and for the removed group at 2 years 15.4 mmHg. The success rates for the intact group at 3.5 years were 25.2% and for the removed group at 4.5 years 64.3%. The results in the intact group were worse than in the POAG patients. Although visual disturbance was seen in 13% of the patients, the major cause was the progression of the cataracts. CONCLUSIONS: The long-term results were the same as those of previous reports on surgery performed superiorly, including the frequency of visual disturbance. However the removal of Schlemm's canal endothelium is necessary in XFG for better IOP control.

Department of Ophthalmology, Kansai Medical University Hirakata Hospital, Japan. nambuh@hirakata.kmu.ac.jp


Classification:

12.9 Trabeculotomy, goniotomy (Part of: 12 Surgical treatment)



Issue 14-3

Change Issue


advertisement

Oculus